BACKGROUND: Directing splicing using oligonucleotides constitutes a promising therapeutic tool for a variety of diseases such as beta-thalassemia, cystic fibrosis, and certain cancers. The rationale is to block aberrant splice sites, thus directing the splicing of the pre-mRNA towards the desired protein product. One of the difficulties in this setup is the poor bioavailability of oligonucleotides, as the most frequently used transfection agents are unsuitable for in vivo use. Here we presen...Expand abstract
- Publisher copy:
- Copyright date:
Induction of splice correction by cell-penetrating peptide nucleic acids.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record